I. Introduction
Tissue bank is defined as an organization that provides donor screening, recovery, processing, storage and distribution of allograft tissue. Beside bone banking tissue banks can be dedicated eye banks, sperm banks, cardiovascular banks, embryo banks, or skin banks. There are dedicated general or multi tissue banks that supply musculoskeletal tissues.
The term ‗graft' is commonly used to refer to either an allograft or an autograft. Tissue allografts are commonly used in orthopaedic surgical procedures. Musculoskeletal allografts are used in a wide variety of orthopaedic surgeries, ranging from anterior cruciate ligament reconstructions to spinal fusions. 1 First human bone transplant using aseptic conditions was occurred in1881. 2 In 2001, U.S. tissue banks distributed approximately 875,000 musculoskeletal allografts, as compared with 350,000 in 1990. 3 The otherwise healthy people often become donors as the result of an unexpected death.Musculoskeletal allografts are safe and the use of these allografts provides the opportunity for improved function and enhancement concerning quality of life. The orthopaedic surgeon also has the responsibility to inform the patient about the risks, benefits, and alternatives of using allograft tissue.
During the last decade, musculoskeletal tissue transplantation has become well establishedinternationally, 4 and tissue banking has gained increasing importance even also in the Asia Pacific region. The awareness of tissue banking and the demand for bone and soft-tissue allografts in this region have increased substantially.
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II. Allografts Used In Orthopaedic Procedures
The Musculoskeletal Transplant Foundation reports that more than 900,000 allografts are used each year in the United States.Connective tissues commonly distributed by the tissue banks are bone-patellar tendonbone (95%),Achilles tendon (90%), fascia lata (86%), and meniscus (33%). 6 The bone-patellar tendon-bone, Achilles tendon, fascia lata, and hamstring tendon allografts are used for ACL reconstruction. Meniscal allografts have become more common in recent years for meniscal transplantation. More recently, osteochondral allografts have been made available by bone banks for transplantation into large focal articular surface defects in the knee. 
III. Donor Screening and Awareness
All tissue bank policies and procedures for donor screening, serologic and microbiologic testing should meet current standards and regulations established by the American Association of Tissue Banks (AATB) and the United States Food and Drug Administration (FDA).
The AAOS believes that musculoskeletal allografts represent a therapeutic alternative for appropriate patients. These tissues should be acquired from facilities that demonstrate compliance, use well-accepted banking methodology and follow Food and Drug Administration (FDA) Good Tissue Practices. After a potential donor is being notified necessary information is obtained to determine donor suitability. A detailed medical/social history is obtained from the donor's next of kin or from someone who can provide reliable donor historical information. This evaluation consists of more than 50 questions on medical history, high-risk social behaviour, unusual environmental exposure, and medical conditions such as cancer. The decision to accept or reject the donor tissue is based on the responses to these questions. A tissue procurement team is sent to the operating room, morgue, or tissue bank facility;acquire the tissue from a suitable donor. The tissue needs to be obtained aseptically within 24 hours of the donor's death, using techniques similar to those used by orthopaedic surgeons in the operating room and under strict guidelines imposed by AATB accreditation.
Using standard surgical principles the donor's limbs are prepped and draped, and the tissue is recovered by an experienced surgical staff. Many types of tissues can be recovered, including stem cells, bone, soft tissues (tendon, ligament) and skin. All grafts are cultured prior to processing to determine the level of bacterial contamination. Fresh articular cartilage is initially refrigerated and then placed in a culture medium to maintain its viability for up to 28 days. If tissue culture results indicate the presence of -virulent organisms‖ such as Clostridia species, enterococci, or fungi, the tissues are discarded. Typically, the recovery/procurement and pre-processing cultures are taken using a swab-culturing technique but it is sometime unreliable. 8 Thus, as part of the final sterility tests, newer techniques, such as bacterial extraction, are used to detect any low levels of bacterial growth. Testing of donor blood and tissue samples began at the site of recovery and continued throughout processing. Donor blood samples taken prior to or at the time of recovery were tested by laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and 42 CFR Part 493 and were found negative using FDA licensed tests 6 Furthermore, important stage of the capture process is donor reconstruction. The body should be delivered to the family free from any deformation and as close as possible to its appearance before the tissue removal. This is because the fear of deformation has been one of the main causes of refusals of bone donation by the family. Strides have been made to have allografts become even safer through further FDA Regulations and Guidelines and AATB Standards and Joint Commission Standards for Tissues.While the incidence of disease transference with allograftsis very low, careful donor screening and tissue processing are crucial in order to minimize potential risk to the recipient. Collaboration by the orthopaediccommunity with a broad range of scientific, tissue bank, regulatory organizations, and clinical interest groups can help ensure that the musculoskeletal allograftsavailable for human transplantation can be used safely. 10 Informed consent is taken, for both the donor family and the recipient of human tissue, in accordance with local, state and federal regulations and laws. The AAOS encourages the establishment of a national network to maximize the availability, equitable distribution and utilization of these scarce transplantable musculoskeletal tissues. Such a network should also serve as a means to acquire data and information reflecting the on-goingclinical experience with musculoskeletal allografts, while providing a vehicle for public and professional education.
IV. Musculoskeletal Tissue Processing 4.1 Principle
Tissue processing is a complex multistage procedure.
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The following principle should be practiced.
•
Aseptic Tissue Processing
Tissues may be contaminated before they reach the tissue-processing facility. This contamination may be the result of an occult infection in the donor, post-mortem invasion of the tissue by bacteria from the gastrointestinal tract, or potential contamination introduced during the recovery process. The term -aseptic processing‖ refers to methods used by a manufacturer to avoid adding contamination to a product. 12 Aseptic processing neither removes contamination nor does it remove all blood, lipids, and other cellular elements from the tissue.
The graft is prepared from tissue procured from a cadaver donor using aseptic surgical techniques. Processing cleaning, cutting, sizing, shaping, container sterilization, and filling are performed using aseptic techniques in a controlled, clean environment. 13 The aseptic handling of the tissue that continues throughout processing and final release is based on a validated sterilization process.
Tissue Sterilization
Sterilization has been defined as the process or act ofinactivating or killing all forms of life, especially microorganisms.
14 However, sterilization of musculoskeletal tissue has associated challenges. Thebiomechanical properties of tissue can be adversely affectedby heat and irradiation. 15 Allsterilizing agents (especially gases and liquids) have not quality of adequatetissue penetration. Without good tissue penetration, sterilitycannot be assured. In contrast to syntheticmaterials such as metals or plastics, musculoskeletal tissuesmay be contaminated with large numbers of organisms(that is, have a high bioburden). 16 The higher thenumber of microorganisms, the longer or more concentratedthe treatment must be to achieve sterilization.Tissue is an organic material that can serve toprotect microorganisms and may cause sterilization-processfailure.To be considered sterile, allografts should have fewer than 10 -6 microorganisms; for medical devices, the requirement is fewer than 10 -3 microorganisms. 13 As noted by the CDC, -When possible, a method that can kill bacterial sporesshould be used to process tissue. Existing sterilizationtechnologies used for tissue allografts, such as gammairradiationor E beam radiation 10-18 kilogray (10 kilogray ~ 1 Mrad) are effective against bacterialspores, should be considered. Unless a sporicidal methodis used, aseptically processed tissue should not be consideredsterile, and health-care providers should be informedof the possible risk for bacterial infection. 
Allograft Storage
Allograft storage is a complex process. Knee allograft tissue preservationbefore storage are cooling and fresh transplantationwithin 24 days, freeze-drying, and deep freezing at -80°Cor -196°C. Preservation and storage methods for the meniscaland ligament tissue can differ significantly fromthose for articular cartilage and bone.
Cryopreservation, a process of controlled-rate freezingwith extraction of cellular water by means of dimethylsulfoxideand glycerol, is one method used for preservingmenisci and ligaments at some tissue banks. Because ofdamage to the cartilage matrix during freezing, cryopreservationof articular cartilage has not proved as satisfactoryas the use of fresh grafts.
A typical cryopreservationprocess may include the following steps: Grafts are initiallycooled to 0°C and processed within 48 hours of donordeath. After decontamination with antimicrobial solutions,allografts are subjected to controlled-rate freezing to-135°C and packed in a cryoprotectant solution. Cryopreservedgrafts can be stored at -196°C for as long as 10years. 18 Deep-freezing is the simplest and most widely usedmethod of ligament and meniscal allograft storage. Afterrecovery, the graft may be frozen, pending the results ofdonor screening and testing, after which it is thawed andprocessed. Freezing to -80°C is typical for frozen storage.It can then be stored for 3 to 5 years.
Freeze-drying (lyophilisation) can be used for ligament, boneand meniscal allografts. Standard graft processing is followedby freezing and lyophilisation to a predeterminedresidual moisture level. The graft can then be vacuum packaged and stored at room temperature for up to 3 to 5years. Rehydration of freeze-dried ligament grafts withattached bone plugs requires a minimum of 30 minutesbefore implantation. 17 Currently, most osteochondral allografts are trans-planted fresh, which better preserves both cartilage cells and matrix. These grafts contain marrow elements within the bone, which increases both the antigen exposures to the recipient and the possibility of disease transmission.
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Viable chondrocytes can be maintained in lactated Ringer's solution cooled to 2° to 4°C for 7 to 14 days. 19 Generally, fresh articular cartilage allograft is transplanted within days of harvesting, with the understanding that the longer the wait, the greater the death of cartilage cells.
V. Common Uses inOrthopaedic Procedures
Indications of allografts transplantation -revision total hip arthroplasty, nonunion of the humerus diaphysis, revision total knee arthroplasty, patellar fracture, humeral fracture, tibia plateau fracture, nonunion of the clavicle, opening wedge osteotomy, osteotomy of the tibia, osteotomy of the femur, humeral head fracture, nonunion of an osteotomy, protrusion of the acetabulum, comminuted elbow fracture, tibia fracture, calcaneal fracture, delayed union of the radius, fracture of an enchondroma, giant cell tumour. This spectrum is expanding day by day.
VI. Evolution of Musculoskeletal Tissue Bank In Bangladesh
Utilization of human tissues has been practicing in many countries and it has a long history. Today it can be seen that tissue transplantations in general are on the rise. Events such as officialization in the legislation and the creation of public promotion policies corroborate this evolution. Considering bone transplants alone, 30 x growths has been observed in the last 5 years (Brazilian Transplantation Register, 2010). The University Hospital Hradec Králové, Czech Republic, established tissue bank in 1952. 20 The gradual demands of allografts have encouraged the development of institutional bone banks, first in the United States and subsequently in other countries. 21, 22, 23 National University of Singapore (NUS) Bone Bank was established in October 1988. 24 International Atomic Energy Agency (IAEA) in 1995 was the first into distance learning in tissue banking. Sri Lanka also started fully operated tissue banking based upon the financial support of IAEA since 1998. 
VII. Conclusion
With the advancement of technology, use of musculoskeletal allograft tissue transplantation will continue to improve and expand which would enhance the patient's quality of life. It is essential that orthopaedic surgeons who use allografttissue understand the tissue banking process and theorigins of the allograft tissue they use. The ethics, moral principles, and legal aspects regarding bone banking should be disseminated enormously to the general public of the countryas they could be more aware and interested to tissue donation thereby more people willcontribute to alleviate sufferings and more lives will save.
